Construction and Validation of a Nomogram Model to Predict the Severity of Mycoplasma pneumoniae Pneumonia in Children

References

• Kutty PK, Jain S, Taylor TH, et al. Mycoplasma pneumoniae among children hospitalized with community-acquired pneumonia. Clin Infect Dis. 2019;68(1):5–12. doi:10.1093/cid/ciy419
   PubMed Web of Science ®Google Scholar
• Gao LW, Yin J, Hu YH, et al. The epidemiology of paediatric Mycoplasma pneumoniae pneumonia in North China: 2006 to 2016. Epidemiol Infect. 2019;147:e192. doi:10.1017/S0950268819000839
   PubMed Web of Science ®Google Scholar
• Lee KL, Lee CM, Yang TL, et al. Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010–2019. J Formos Med Assoc. 2021;120(1 Pt 1):281–291. doi:10.1016/j.jfma.2020.08.018
   PubMed Web of Science ®Google Scholar
• Moynihan KM, Barlow A, Nourse C, Heney C, Schlebusch S, Schlapbach LJ. Severe mycoplasma pneumoniae infection in children admitted to pediatric intensive care. Pediatr Infect Dis J. 2018;37(12):e336–e338. doi:10.1097/INF.0000000000002029
   PubMed Web of Science ®Google Scholar
• Commission GOotNH. Guideline for diagnosis and treatment of mycoplasma pneumoniae pneumonia in children; 2023. Available from: http://www.gov.cn/zhengce/zhengceku/2023-02/16/content_5741770.htm. Accessed March 9, 2023.
   Google Scholar
• Ni X. Diagnosis and treatment of community acquired pneumonia in children. In: General Medicine and Education. Vol. 17. Wiley Online Library; 2019:771–777.
   Google Scholar
• Lv YT, Sun XJ, Chen Y, Ruan T, Xu GP, Huang JA. Epidemic characteristics of Mycoplasma pneumoniae infection: a retrospective analysis of a single center in Suzhou from 2014 to 2020. Ann Transl Med. 2022;10(20):1123. doi:10.21037/atm-22-4304
   PubMed Web of Science ®Google Scholar
• Pechous RD. With friends like these: the complex role of neutrophils in the progression of severe pneumonia. Front Cell Infect Microbiol. 2017;7:160. doi:10.3389/fcimb.2017.00160
   PubMed Web of Science ®Google Scholar
• Yan C, Xue G, Zhao H, et al. Molecular and clinical characteristics of severe Mycoplasma pneumoniae pneumonia in children. Pediatr Pulmonol. 2019;54(7):1012–1021. doi:10.1002/ppul.24327
   PubMed Web of Science ®Google Scholar
• Bi Y, Zhu Y, Ma X, et al. Development of a scale for early prediction of refractory Mycoplasma pneumoniae pneumonia in hospitalized children. Sci Rep. 2021;11(1):6595. doi:10.1038/s41598-021-86086-5
   PubMed Web of Science ®Google Scholar
• Gendrel D, Raymond J, Moulin F, et al. Etiology and response to antibiotic therapy of community-acquired pneumonia in French children. Eur J Clin Microbiol Infect Dis. 1997;16(5):388–391. doi:10.1007/BF01726370
   PubMed Web of Science ®Google Scholar
• Juven T, Mertsola J, Waris M, et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J. 2000;19(4):293–298. doi:10.1097/00006454-200004000-00006
   PubMed Web of Science ®Google Scholar
• Chiu CY, Chen CJ, Wong KS, Tsai MH, Chiu CH, Huang YC. Impact of bacterial and viral coinfection on mycoplasmal pneumonia in childhood community-acquired pneumonia. J Microbiol Immunol Infect. 2015;48(1):51–56. doi:10.1016/j.jmii.2013.06.006
   PubMedGoogle Scholar
• Zhou Y, Wang J, Chen W, et al. Impact of viral coinfection and macrolide-resistant mycoplasma infection in children with refractory Mycoplasma pneumoniae pneumonia. BMC Infect Dis. 2020;20(1):633. doi:10.1186/s12879-020-05356-1
   PubMed Web of Science ®Google Scholar
• Liu J, Wang M, Zhao Z, et al. Viral and bacterial coinfection among hospitalized children with respiratory tract infections. Am J Infect Control. 2020;48(10):1231–1236. doi:10.1016/j.ajic.2020.01.013
   PubMed Web of Science ®Google Scholar
• Zou Y. Clinical significance of abnormal inflammatory markers in mycoplasma pneumoniae pneumonia. Chin J Appl Clin Pediatr. 2021;24:1209–1214.
   Google Scholar
• Oishi T, Narita M, Matsui K, et al. Clinical implications of interleukin-18 levels in pediatric patients with Mycoplasma pneumoniae pneumonia. J Infect Chemother. 2011;17(6):803–806. doi:10.1007/s10156-011-0265-7
   PubMed Web of Science ®Google Scholar
• Miyashita N, Kawai Y, Inamura N, et al. Setting a standard for the initiation of steroid therapy in refractory or severe Mycoplasma pneumoniae pneumonia in adolescents and adults. J Infect Chemother. 2015;21(3):153–160. doi:10.1016/j.jiac.2014.10.008
   PubMed Web of Science ®Google Scholar
• Izumikawa K. Clinical features of severe or fatal mycoplasma pneumoniae pneumonia. Front Microbiol. 2016;7:800. doi:10.3389/fmicb.2016.00800
   PubMed Web of Science ®Google Scholar
• Lu A, Wang C, Zhang X, Wang L, Qian L. Lactate dehydrogenase as a biomarker for prediction of refractory mycoplasma pneumoniae pneumonia in children. Respir Care. 2015;60(10):1469–1475. doi:10.4187/respcare.03920
   PubMed Web of Science ®Google Scholar
• Liu TY, Lee WJ, Tsai CM, et al. Serum lactate dehydrogenase isoenzymes 4 plus 5 is a better biomarker than total lactate dehydrogenase for refractory Mycoplasma pneumoniae pneumonia in children. Pediatr Neonatol. 2018;59(5):501–506. doi:10.1016/j.pedneo.2017.12.008
   PubMed Web of Science ®Google Scholar
• Zheng HQ, Ma YC, Chen YQ, Xu YY, Pang YL, Liu L. Clinical analysis and risk factors of bronchiolitis obliterans after mycoplasma pneumoniae pneumonia. Infect Drug Resist. 2022;15:4101–4108. doi:10.2147/IDR.S372940
   PubMed Web of Science ®Google Scholar
• Miyashita N, Obase Y, Ouchi K, et al. Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit. J Med Microbiol. 2007;56(Pt 12):1625–1629. doi:10.1099/jmm.0.47119-0
   PubMed Web of Science ®Google Scholar
• Chen Q, Shen K, X ZD. Relationship between serum ferritin level and severity of community-acquired pneumonia in children. Chin J Pract Pediatr. 2018;22(10):753–757.
   Google Scholar
• Li G, Ye H. Correlation analysis of serum interleukin-18 and ferritin levels with disease severity in children with Mycoplasma pneumoniae pneumonia. China Maternal Child Health Care. 2022;37(12):2206–2208.
   Google Scholar
• Kyriazopoulou E, Leventogiannis K, Norrby-Teglund A, et al. Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis. BMC Med. 2017;15(1):172. doi:10.1186/s12916-017-0930-5
   PubMed Web of Science ®Google Scholar
• Horvat CM, Fabio A, Nagin DS, et al. Mortality risk in pediatric sepsis based on c-reactive protein and ferritin levels. Pediatr Crit Care Med. 2022;23(12):968–979. doi:10.1097/PCC.0000000000003074
   PubMed Web of Science ®Google Scholar
• Zhou Y, Qi M, Yang M. Current status and future perspectives of lactate dehydrogenase detection and medical implications: a review. Biosensors. 2022;12:12.
   Google Scholar